Search results for “Substitution therapy” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,372 patents, we discovered top 268 key players by total patent application. Genzyme Corp., Schering AG, Bayer Schering Pharma AG are dominant in this area. They take 22.45% of the total patent filing.
Genzyme Corp.
Massachusetts, United States
Patent: 128
Schering AG
Berlin, Germany
Patent: 120
Bayer Schering Pharma AG
Berlin, Germany
Patent: 60
Estetra SPRL
Luxembourg, Belgium
Patent: 45
TherapeuticsMD, Inc.
United States
Patent: 36
Wyeth Ltd. (India)
Maharashtra, India
Patent: 35
Merck & Co., Inc.
New Jersey, United States
Patent: 24
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 22
Jenapharm GmbH & Co. KG
Thüringen, Germany
Patent: 22
McNeil AB
Sweden
Patent: 21
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 7 start-ups by total patent application. Renibus Therapeutics, Inc., Myodopa Ltd., Marius Pharmaceuticals LLC are active in this area.
STARTUP
Renibus Therapeutics, Inc.
United States
Patent: 6
STARTUP
Myodopa Ltd.
SURREY, United Kingdom
Patent: 4
STARTUP
Marius Pharmaceuticals LLC
North Carolina, United States
Patent: 2
STARTUP
Qidni Labs, Inc.
Ontario, Canada
Patent: 1
STARTUP
Forty Seven, Inc.
California, United States
Patent: 1
STARTUP
ZyVersa Therapeutics Operating, Inc.
United States
Patent: 1
STARTUP
Ethos Biosciences, Inc.
Pennsylvania, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 485 patents applied in the last 5 years. We discover 124 most active companies in this area. The fast-growing Genzyme Corp., Estetra SPRL, Regents of the University of Colorado take 27.01% of patent filing during this period.
Genzyme Corp.
Massachusetts, United States
Patent: 66
Estetra SPRL
Luxembourg, Belgium
Patent: 42
Regents of the University of Colorado
Colorado, United States
Patent: 23
McNeil AB
Sweden
Patent: 18
Glycomine, Inc.
California, United States
Patent: 16
Acerus Biopharma Inc
United States
Patent: 14
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 9
TherapeuticsMD, Inc.
United States
Patent: 9
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 9
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 8
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 485 patents in last 5 years, we discover 88 new entrants. Intra-Cellular Therapies, Inc., SphingoTec GmbH, Millicent Pharma Ltd. are the most active new entrants in this area.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 9
SphingoTec GmbH
Brandenburg, Germany
Patent: 7
Millicent Pharma Ltd.
DUBLIN, Ireland
Patent: 7
STARTUP
Renibus Therapeutics, Inc.
United States
Patent: 6
McLean Hospital, Inc.
Massachusetts, United States
Patent: 5
Ablevia biotech GmbH
Wien, Austria
Patent: 4
THE MENOPAUSE METHOD, INC.
United States
Patent: 4
Aytu Biopharma, Inc.
Colorado, United States
Patent: 4
EirGen Pharma Ltd.
WATERFORD, Ireland
Patent: 4
Larimar Therapeutics, Inc.
Pennsylvania, United States
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 275 patents, we discovered top 45 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Regents of the University of Colorado, Western University of Health Sciences are dominant in this area. They take 30.18% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 31
Regents of the University of Colorado
Colorado, United States
Patent: 31
Western University of Health Sciences
California, United States
Patent: 8
University of Minnesota
Minnesota, United States
Patent: 6
University of Gottingen
Niedersachsen, Germany
Patent: 6
Duke University
North Carolina, United States
Patent: 5
St. Louis University
Missouri, United States
Patent: 5
Wake Forest University
North Carolina, United States
Patent: 5
Texas A&M University
Texas, United States
Patent: 4
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: